BP
Boobalan Pachaiyappan Roth Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
0.55%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $17 |
344%
upside
| 1 | -3.6% |
0
%
| 15 Oct ‘25 5 days ago |
|
|
|
Buy
Initiated
| $62 |
27%
upside
| 1 | +18% |
0
%
| 17 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $3 |
443%
upside
| 1 | -34% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $3 |
273%
upside
| 1 | -28% |
0
%
| 15 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $6 |
214%
upside
| 1 | +2.1% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $16 |
116%
upside
| 1 | +53% |
0
%
| 12 Aug ‘25 2 months ago |
|